Cargando…
UHPLC Enantiomer Resolution for the ɑ/β-Adrenoceptor Antagonist R/S-Carvedilol and Its Major Active Metabolites on Chiralpak IB N-5
Carvedilol (CAR), a racemic lipophilic aryloxy propanolamine, acts as a selective α(1)-adrenoreceptor antagonist and a nonselective β-adrenoreceptor antagonist. CAR metabolism mainly produces three active metabolites: desmethyl carvedilol (DMC), 4′-hydroxy carvedilol (4′OHC) and 5′-hydroxy carvedilo...
Autores principales: | Samir, Liza, Hanafi, Rasha, El Deeb, Sami, Spahn-Langguth, Hilde |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370150/ https://www.ncbi.nlm.nih.gov/pubmed/35956942 http://dx.doi.org/10.3390/molecules27154998 |
Ejemplares similares
-
Reversed-Phase UHPLC Enantiomeric Separation of Rasagiline Salts Using a Chiralpak(®) AGP Column
por: Balaji, Nagarajan, et al.
Publicado: (2017) -
How Carvedilol activates β(2)-adrenoceptors
por: Benkel, Tobias, et al.
Publicado: (2022) -
How carvedilol does not activate β(2)-adrenoceptors
por: Lefkowitz, Robert J., et al.
Publicado: (2023) -
Transfersome Encapsulated with the R-carvedilol Enantiomer for Skin Cancer Chemoprevention
por: Shamim, Md Abdullah, et al.
Publicado: (2023) -
Reply to: How carvedilol does not activate β(2)-adrenoceptors
por: Kostenis, Evi, et al.
Publicado: (2023)